Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Venus Concept Inc. (VERO) is a global medical aesthetics technology company focused on developing, manufacturing, and commercializing minimally invasive and non-invasive aesthetic and medical devices. The company operates within the medical aesthetics, dermatology, and plastic surgery industries, serving physicians, aesthetic clinics, and medical spas. Its core offerings historically centered on energy-based devices used for skin resurfacing, body contouring, hair restoration, and skin tightening, with revenue generated through capital equipment sales, consumables, and recurring treatment-based products.
Founded in 2009, the company built its market position around proprietary radiofrequency (RF) and electromagnetic technologies, notably its multi-application platforms. Venus Concept pursued an integrated model combining hardware, single-use consumables, and service contracts. Over time, the company expanded its portfolio through internal development and acquisitions, though its growth trajectory has been impacted by financial restructuring efforts. Public disclosures indicate periods of liquidity constraints and restructuring, and certain operational details after 2023 are data inconclusive based on available public sources.
Business Operations
Venus Concept historically operated through several core product families, including Venus Legacy, Venus Versa, Venus Bliss, Venus Viva, and Venus Velocity, each addressing different aesthetic indications. The company generated revenue primarily through system placements, recurring consumable sales, and service agreements. Operations spanned product development, manufacturing oversight, direct sales, distributor-based sales, and post-sale clinical support. Its technology portfolio emphasized proprietary RF platforms, pulsed electromagnetic fields, and combination therapy systems.
The company conducted both domestic and international operations, selling products through direct sales teams in key markets and independent distributors elsewhere. Venus Concept maintained subsidiaries and operating entities across multiple jurisdictions to support sales and regulatory compliance. Public filings indicate reliance on third-party manufacturers for certain components and finished devices, with quality control and intellectual property retained internally. Some operational arrangements following restructuring activities are data inconclusive based on available public sources.
Strategic Position & Investments
Strategically, Venus Concept positioned itself as a provider of multi-indication platforms designed to maximize clinic utilization and recurring revenue per installed system. Growth initiatives emphasized expanding consumables penetration, launching next-generation platforms, and increasing presence in underpenetrated international markets. The company also invested in clinical studies and regulatory clearances to expand approved indications for existing systems.
Venus Concept pursued selective acquisitions to broaden its technology base and treatment offerings, including the acquisition of NeoGraft to enter the hair restoration segment. Investment priorities historically focused on innovation in RF-based treatments, body contouring technologies, and patient comfort optimization. Due to financial restructuring and changes in ownership status, details regarding current investment activity and long-term strategic initiatives are data inconclusive based on available public sources.
Geographic Footprint
Venus Concept maintained a global operational footprint with corporate headquarters historically based in Toronto, Canada, and significant commercial operations in the United States. The company sold products across North America, Europe, Asia-Pacific, Latin America, and the Middle East, using a mix of direct sales and distributor partnerships.
International presence included subsidiaries and sales offices supporting regulatory approvals, training, and customer support in major aesthetic markets. The company’s devices were marketed in dozens of countries, reflecting a broad international reach. However, the scale and continuity of operations in certain regions following restructuring activities remain data inconclusive based on available public sources.
Leadership & Governance
Venus Concept was founded by Domenic Serafino, who played a central role in shaping its technology-driven and vertically integrated business model. The company has experienced leadership transitions over time, particularly in connection with strategic realignments and restructuring efforts. Governance historically included a board of directors with experience in medical devices, finance, and global operations.
Key executives disclosed in public filings and corporate communications include:
- Domenic Serafino – Founder and former Chief Executive Officer
- Rajiv De Silva – Former Chief Executive Officer
- Patrick O’Shaughnessy – Former Chief Financial Officer
- Andrew Markarian – Former Chief Operating Officer
Leadership philosophy emphasized innovation, recurring revenue models, and global scalability. Current executive leadership details following recent corporate changes are data inconclusive based on available public sources.